Azilect 0.5 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is inadequate, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be administered to certain patients. First, patients who are allergic to the main ingredient or other components of this medication should not take it. Additionally, patients who are currently taking or have discontinued other MAO inhibitors within the past 2 weeks should also avoid this medication. In particular, patients who are currently taking or have recently stopped medications such as pethidine, tramadol, or dextromethorphan should avoid this medication. Patients with moderate or severe liver impairment should not take this medication. Various adverse reactions may occur when taking this medication. Commonly reported side effects include headache, dizziness, depression, hallucinations, dermatitis, myalgia, arthralgia, nausea, constipation, and insomnia. Serious side effects such as hypertension, hypotension, movement disorders, and impulse control disorders may also occur, so caution is advised. This medication may require dosage adjustments in patients with impaired liver and kidney function, and it should not be given to patients with severe liver impairment. Elderly patients can use it without special dosage adjustments, but caution should be exercised while driving or operating machinery due to potential drowsiness or sudden sleep occurrences during treatment. This medication has many drug interactions, so it is essential to consult a doctor or pharmacist regarding concomitant medications. In particular, serious side effects may occur when used in combination with MAO inhibitors, antidepressants, pethidine, tramadol, dextromethorphan, or sympathomimetics. Pregnant or nursing women should exercise caution when taking this medication, and its safety and efficacy for children have not been established. In the case of overdose, symptoms such as mild mania, hypertensive crisis, and serotonin syndrome may occur, necessitating immediate medical assistance, and there is no specific antidote. This medication should be stored out of the reach of children and kept at a temperature between 1°C and 25°C. It is also advisable not to transfer it to another container.

• Influenza
• skin cancer
• leukopenia
• allergy
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is recommended to store it at a cool temperature between 1°C and 25°C.

Appearance

A white or almost white, flat, round tablet with a beveled edge, engraved with "GIL" on the top side and "0.5" on the bottom side.

Package unit

30 tablets/bottle